We covered the cost effectiveness of screening in this #NephJCShorts
www.nephjc.com/news/2025/7/...
#CSNHomecoming
#NephJCshorts
🤔 How often is end-stage kidney disease in patients with MCD/ FSGS? #NephSky #MedSky
@brianrifkin.bsky.social dissected the conclusions from the RaDar study in this #NephJCshorts
*the original article from @asnpublications.bsky.social
www.nephjc.com/news/nephjc-...
👇Read last #NephJCshorts by @hswapnil.medsky.social
✍️On CKD screening cost-efficiency in general population
🎨 Visuals by @nephroseeker.medsky.social
Another #NephJCshorts, by @hswapnil.medsky.social
✍️Edited by @kidneyboy.bsky.social
🎨VA by @nephroseeker.medsky.social
🌊The long discussions mirror the old FLUID war. Despite the nuances, the conclusion is firm: Ringer's lactate offers no benefit over NS
www.nephjc.com/news/fluid-t...
#NephJCshorts #MedSky #NephSky
✂️🌱Cutting the renin-angiotensin axis from the angiotensinogen roots using RNA interference via zilebesiran
✍️by @hswapnil.medsky.social
www.nephjc.com/news/2025/17...
We don’t get to discuss every important study that comes out on #NephJC
Hence #NephJCShorts
www.nephjc.com/news/nephjc-...
The #NephJC editorial team knows that plenty of papers deserve attention between our bi-monthly, full-length discussions
✨Enter #NephJCShorts - quick hits with a critical eye 🦅 on high-impact reads
www.nephjc.com/news/nephjc-...
#MedSky #NephSky